Screener

Research And Development Stock Based Compensation

Name: Crinetics Pharmaceuticals Research And Development Stock Based Compensation by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Crinetics Pharmaceuticals·Business Segments·1 segment

Breakdown

Segment	Q3 '25	Q4 '25	Q1 '26
Business Segments	$13M	$12.42M	$19.33M
Total	$13M	$12.42M	$19.33M

Segments

Business SegmentsView metric